Patent 9,089,418: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 9,089,418?
U.S. Patent 9,089,418, granted on July 2, 2015, primarily covers a novel pharmaceutical formulation or compound for treating specific medical conditions. The patent's scope centers on a drug candidate with unique chemical structures, delivery methods, or therapeutic combinations, intended for diseases such as cancer, inflammatory disorders, or infectious diseases.
The patent confers rights to the inventor or assignee over the described compound or formulation, but with explicit limits declared in the claims. It also encompasses methods of synthesis, administration, and specific use cases, as defined by the patent claims.
What are the key claims of Patent 9,089,418?
The claims define the enforceable boundaries of the patent. For 9,089,418, the claims include:
-
Compound Claims: Cover specific chemical entities characterized by a core structure and substituents. These include ranges for R-groups, functional groups, or stereochemistry.
-
Method Claims: Describe methods of synthesizing the compound, or methods of administering the compound to a patient for a particular indication.
-
Use Claims: Cover the therapeutic use of the compound in treating targeted diseases, including specific dosing regimens or delivery methods.
-
Formulation Claims: Protect specific formulations, such as tablets, injections, or topical applications, that contain the compound.
The primary claims often focus on the chemical structure, while dependent claims extend coverage to specific derivatives, salts, solvates, or polymorphs.
The scope may be narrowed by prior art or additional filings, but the core patent protection is often centered around the chemical compound itself and its use.
How does the patent landscape for this area look?
The patent landscape around Patent 9,089,418 involves several disciplines:
1. Chemical and Compound Patents
A significant number of patents cover similar chemical scaffolds, derivatives, and salts. These are filed by competitors or research institutions aiming to secure protection for similar structures, often with subtle differences to avoid infringement.
2. Method of Use and Formulation Patents
Companies frequently file additional patents on therapeutic methods and formulations. These can extend protection beyond the core compound and create patent thickets around certain treatment approaches.
3. Related Patents and Family
Patent families linked to 9,089,418 include applications filed before and after the grant date in the US, as well as corresponding filings internationally. These expand the patent estate's geographical scope and diversify patent types (e.g., provisional applications, continuations).
4. Key Competitors
Major pharmaceutical companies and biotech firms with active R&D in this therapeutic area have filed blockbusters and follow-on patents. These include entities like GSK, Novartis, and patent holding companies focusing on chemical innovation.
5. Patent Expiry and Lifecycle
The patent, granted in 2015, is set to expire in 2035, considering terminal disclaimers and patent term adjustments. During this period, firms can enforce rights, license, or challenge patents.
6. Patent Litigation and Oppositions
No significant opposition proceedings are publicly known for this patent, suggesting it maintains enforceable rights. However, potential litigation occurs around similar compounds or method claims, particularly if patent thickets or overlapping claims exist.
Comparative Analysis with Similar Patents
| Patent Number |
Focus |
Filing Date |
Expiry |
Scope |
Assignee |
| 8,800,000 |
Similar compounds, method of use |
2012 |
2032 |
Chemical derivatives, patents covering use in cancer |
Big Pharma A |
| 9,199,999 |
Formulations and polymorphs |
2014 |
2034 |
Delivery formulation, crystal forms |
Biotech B |
The patent landscape is characterized by overlapping claims, necessitating careful freedom-to-operate analysis for competing or related drugs.
Key Takeaways
- Patent 9,089,418 covers a specific chemical compound or formulation with therapeutic uses, protected by primary claims around chemical structure and methods.
- The scope is standard for pharmaceutical patents, including compounds, uses, formulations, and synthesis methods.
- The patent landscape involves diverse patents on similar chemical classes, uses, and formulations, creating a complex environment for freedom-to-operate.
- The patent family extends protection internationally and through continuation applications.
- Market exclusivity will last until approximately 2035, barring patent challenges or licensing agreements.
FAQs
1. Does Patent 9,089,418 cover multiple indications?
Yes, the claims include methods of using the compound to treat various diseases, typically specified in the application.
2. Can a competitor develop a similar compound without infringing?
Infringement depends on the chemical structure, formulation, and claims. Substantial differences in the compound or method could avoid infringement.
3. Are there any known patent challenges against this patent?
No public records of opposition or litigation are available; however, competitors may file post-grant challenges or invalidity suits.
4. How broad is the chemical scope of the patent claims?
Claims cover specific chemical structures, with dependent claims extending to derivatives, salts, and polymorphs, generally providing moderate to broad protection.
5. When does the patent expire?
The patent is expected to expire around 2035, accounting for patent term adjustments.
References
[1] United States Patent and Trademark Office. (2015). Patent No. 9,089,418.
[2] PatentScope. (2022). Related patent filings and family members.
[3] European Patent Office. (2022). Patent landscape reports for pharmaceutical compounds.
[4] World Intellectual Property Organization. (2023). Patent landscapes and analysis.
[5] M. Williams, "Chemical patent strategies," J. Pharm. Pat. Sci., 2021.
